Nitib 140 mg

Nitib 140 mg is a prescription medicine containing Ibrutinib 140 mg. It is an oral targeted anticancer medicine used for selected B-cell blood cancers, such as chronic lymphocytic leukemia/small lymphocytic lymphoma, mantle cell lymphoma, and Waldenström’s macroglobulinemia, depending on the oncologist’s diagnosis and treatment plan. Small capsule, huge “do not self-medicate unless you enjoy chaos” energy. Ibrutinib is a kinase inhibitor used for several B-cell malignancies.

Composition:

Ibrutinib – 140 mg

Key Information:

Brand Name: Nitib
Strength: 140 mg
Active Ingredient: Ibrutinib
Dosage Form: Capsules
Medicine Type: Anticancer medicine / Targeted therapy / BTK inhibitor
Manufacturer/Brand Shown: To be verified from physical label
Common Use: Treatment of selected B-cell blood cancers
Other Prescribed Uses: CLL/SLL, mantle cell lymphoma, Waldenström’s macroglobulinemia, and other specialist-directed uses
Administration: Oral use
Category: Prescription medicine
Pack Size: 30 capsules, as visible on the pack

How It Works:

Nitib 140 mg works by blocking Bruton’s tyrosine kinase, also called BTK, a protein involved in the growth and survival of certain abnormal B-cells. By blocking BTK signaling, ibrutinib may help slow the growth of some blood cancer cells when taken exactly as prescribed.

Potential Indications:

• Chronic lymphocytic leukemia, also called CLL
• Small lymphocytic lymphoma, also called SLL
• Mantle cell lymphoma, also called MCL
• Waldenström’s macroglobulinemia, also called WM
• Other oncologist-directed use based on diagnosis and reports

Dosage & Storage:

Take only as directed by a qualified healthcare professional.
Follow the dosage instructions printed on the label or prescribed by the doctor.
For some approved indications, ibrutinib dosing may involve multiple 140 mg capsules once daily, but the exact dose and duration must be decided by the treating oncologist.
Store in a cool, dry place away from direct sunlight and moisture.
Keep out of reach of children.

Important Safety Information:

Ibrutinib should be used carefully under medical supervision, especially in patients with bleeding risk, heart rhythm problems, high blood pressure, liver problems, infection risk, or those taking blood thinners or interacting medicines.

Possible side effects may include:

• Diarrhea
• Nausea
• Fatigue or weakness
• Muscle or joint pain
• Bruising
• Bleeding
• Rash
• Fever
• Low blood cell counts
• Increased risk of infection
• High blood pressure
• Irregular heartbeat in some patients

Serious symptoms such as unusual bleeding, black stools, blood in urine, severe headache, chest pain, shortness of breath, fever, infection signs, or irregular heartbeat should be reported to a doctor immediately.

Label Verification:

Please double-check the physical product label before listing or use, including the product name, strength, active ingredient, manufacturer details, batch number, expiry date, storage instructions, dosage directions, route of administration, and packaging information.

General Information Disclaimer:

The information provided here is for general educational and product-identification purposes only. It should not be considered medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before starting, stopping, or changing any medication regimen.